Inactive Instrument

News Impax Laboratories Inc Nasdaq

Equities

US45256B1017

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Goldman Sachs Adjusts Amneal Pharmaceuticals Price Target to $8 From $6.25, Maintains Buy Rating	May. 06	MT
Amneal Reports First Quarter 2024 Financial Results	May. 06	AQ
Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating	May. 03	MT
Drugmaker Amneal agrees to $270 million U.S. opioid settlement	May. 03	RE
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	May. 03	MT
Transcript : Amneal Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 03, 2024	May. 03
Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb	May. 03	MT
Amneal Pharmaceuticals : First Quarter 2024 Earnings Presentation	May. 03	PU
(AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63	May. 03	MT
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, vs. Street Est of $619M	May. 03	MT
Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Posts Q1 EPS $0.14, vs. Street Est of $0.09	May. 03	MT
North American Morning Briefing : Apple, Amgen -2-	May. 03	DJ
Amneal: Q1 Earnings Snapshot	May. 03	AQ
Amneal Reports First Quarter 2024 Financial Results	May. 03	BU
Amneal Pharmaceuticals, Inc. Affirms Earnings Guidance for Full Year 2024	May. 03	CI
Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03	CI
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug	Apr. 29	AQ
Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	Apr. 24	MT
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray	Apr. 24	DJ
Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose	Apr. 24	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Impax Laboratories Inc Nasdaq

Equities

US45256B1017

Summary

Filters